X4 Pharmaceuticals Inc Dr. Ragan Discusses X4’s Work To Advance Disease-Modifying Therapies For Rare Genetic Diseases Transcript - Thomson StreetEvents

X4 Pharmaceuticals Inc Dr. Ragan Discusses X4’s Work To Advance Disease-Modifying Therapies For Rare Genetic Diseases Transcript

X4 Pharmaceuticals Inc Dr. Ragan Discusses X4’s Work To Advance Disease-Modifying Therapies For Rare Genetic Diseases Transcript - Thomson StreetEvents
X4 Pharmaceuticals Inc Dr. Ragan Discusses X4’s Work To Advance Disease-Modifying Therapies For Rare Genetic Diseases Transcript
Published Dec 23, 2020
Published Dec 23, 2020
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of XFOR.OQ corporate analyst meeting

  
Report Type:

Transcript

Source:
Company:
X4 Pharmaceuticals Inc
Ticker
XFOR.OQ
Time
10:59am GMT
Format:
PDF Adobe Acrobat
Buy Now

X4 Pharmaceuticals Inc Q3 2021 Earnings Call Transcript – 2021-11-04 – US$ 54.00 – Edited Transcript of XFOR.OQ earnings conference call or presentation 4-Nov-21 1:05pm GMT

X4 Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript – 2021-09-30 – US$ 54.00 – Edited Transcript of XFOR.OQ presentation 30-Sep-21 2:00pm GMT

X4 Pharmaceuticals Inc Q2 2021 Earnings Call Transcript – 2021-08-03 – US$ 54.00 – Edited Transcript of XFOR.OQ earnings conference call or presentation 3-Aug-21 12:30pm GMT

X4 Pharmaceuticals Inc Q1 2021 Earnings Call Transcript – 2021-05-06 – US$ 54.00 – Edited Transcript of XFOR.OQ earnings conference call or presentation 6-May-21 12:30pm GMT

X4 Pharmaceuticals Inc Q4 2020 Earnings Call Transcript – 2021-03-04 – US$ 54.00 – Edited Transcript of XFOR.OQ earnings conference call or presentation 4-Mar-21 1:30pm GMT

X4 Pharmaceuticals Inc Q3 2020 Earnings Call Transcript – 2020-11-05 – US$ 54.00 – Edited Transcript of XFOR.OQ earnings conference call or presentation 5-Nov-20 1:30pm GMT

X4 Pharmaceuticals Inc Q2 2020 Earnings Call Transcript – 2020-07-30 – US$ 54.00 – Edited Transcript of XFOR.OQ earnings conference call or presentation 30-Jul-20 12:30pm GMT

X4 Pharmaceuticals Inc Post-EHA Corporate Update Transcript – 2020-06-12 – US$ 54.00 – Edited Transcript of XFOR.OQ conference call or presentation 12-Jun-20 12:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "X4 Pharmaceuticals Inc Dr. Ragan Discusses X4’s Work To Advance Disease-Modifying Therapies For Rare Genetic Diseases Transcript" Dec 23, 2020. Alacra Store. May 04, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/X4-Pharmaceuticals-Inc-Dr-Ragan-Discusses-X4-s-Work-To-Advance-Disease-Modifying-Therapies-For-Rare-Genetic-Diseases-T15552353>
  
APA:
Thomson StreetEvents. (2020). X4 Pharmaceuticals Inc Dr. Ragan Discusses X4’s Work To Advance Disease-Modifying Therapies For Rare Genetic Diseases Transcript Dec 23, 2020. New York, NY: Alacra Store. Retrieved May 04, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/X4-Pharmaceuticals-Inc-Dr-Ragan-Discusses-X4-s-Work-To-Advance-Disease-Modifying-Therapies-For-Rare-Genetic-Diseases-T15552353>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.